Recent studies suggest that the serine/threonine kinase protein kinase B (PKB or Akt) is involved in the pathway for insulin-stimulated glucose transporter 4 (GLUT4) translocation and glucose uptake. In this study we examined the components of the Akt signaling pathway in skeletal muscle and adipose tissue in vivo from C57BL/KsJ-Lepr(db/db) mice (db/db), a model of obesity, insulin resistance, and type II diabetes. There were no changes in the protein levels of GLUT4, p85alpha, or Akt in tissues from db/db mice compared with non-diabetic littermate controls (+/+). In response to acute insulin administration, GLUT4 recruitment to the plasma membrane increased twofold in muscle and adipose tissue from +/+ mice, but was significantly reduced by 42-43% (P<0.05) in both tissues from db/db mice. Insulin increased Akt-Ser(473) phosphorylation by two- to fivefold in muscle and adipose tissue from all mice. However, in db/db mice, maximal Akt-Ser(473) phosphorylation was decreased by 32% (P<0.05) and 69% (P<0.05) in muscle and adipose tissue respectively. This decreased phosphorylation in db/db mice corresponded with a significant decrease in maximal Akt kinase activity using a glycogen synthase kinase-3 fusion protein as a substrate (P<0.05). The level of insulin-stimulated tyrosine phosphorylation of p85alpha from phosphatidylinositol 3 (PI 3)-kinase, which is upstream of Akt, was also reduced in muscle and adipose tissue from db/db mice (P<0.05); however, there was no change in extracellular signal-regulated kinase-1 or -2 phosphorylation. These data implicate decreased insulin-stimulated Akt kinase activity as an important component underlying impaired GLUT4 translocation and insulin resistance in tissues from db/db mice. However, impaired insulin signal transduction appears to be specific for the PI 3-kinase pathway of insulin signaling, while the MAP kinase pathway remained intact.

This article has been cited by other articles:

				A. J. Hoy, C. R. Bruce, A. Cederberg, N. Turner, D. E. James, G. J. Cooney, and E. W. Kraegen Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1358 - E1364. [Abstract] [Full Text] [PDF]

				J. H. Kim, T. P Stewart, M. Soltani-Bejnood, L. Wang, J. M Fortuna, O. A Mostafa, N. Moustaid-Moussa, A. M Shoieb, M. F McEntee, Y. Wang, et al. Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice. J. Endocrinol., November 1, 2006; 191(2): 437 - 446. [Abstract] [Full Text] [PDF]

				A. D. Hafstad, G. H. Solevag, D. L. Severson, T. S. Larsen, and E. Aasum Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1763 - H1769. [Abstract] [Full Text] [PDF]

				B. Clodfelder-Miller, P. De Sarno, A. A. Zmijewska, L. Song, and R. S. Jope Physiological and Pathological Changes in Glucose Regulate Brain Akt and Glycogen Synthase Kinase-3 J. Biol. Chem., December 2, 2005; 280(48): 39723 - 39731. [Abstract] [Full Text] [PDF]

				K. Fukui, T. Wada, S. Kagawa, K. Nagira, M. Ikubo, H. Ishihara, M. Kobayashi, and T. Sasaoka Impact of the Liver-Specific Expression of SHIP2 (SH2-Containing Inositol 5'-Phosphatase 2) on Insulin Signaling and Glucose Metabolism in Mice Diabetes, July 1, 2005; 54(7): 1958 - 1967. [Abstract] [Full Text] [PDF]

				R. Carroll, A. N. Carley, J. R. B. Dyck, and D. L. Severson Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E900 - E906. [Abstract] [Full Text] [PDF]

				T. Yasukawa, E. Tokunaga, H. Ota, H. Sugita, J. A. J. Martyn, and M. Kaneki S-Nitrosylation-dependent Inactivation of Akt/Protein Kinase B in Insulin Resistance J. Biol. Chem., March 4, 2005; 280(9): 7511 - 7518. [Abstract] [Full Text] [PDF]

				H. Sugita, M. Kaneki, M. Sugita, T. Yasukawa, S. Yasuhara, and J. A. J. Martyn Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E585 - E591. [Abstract] [Full Text] [PDF]

				J. Venugopal, K. Hanashiro, Z.-Z. Yang, and Y. Nagamine Identification and modulation of a caveolae-dependent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes PNAS, December 7, 2004; 101(49): 17120 - 17125. [Abstract] [Full Text] [PDF]

				Y. Hirose, K. Hata, T. Kuno, K. Yoshida, K. Sakata, Y. Yamada, T. Tanaka, B. S. Reddy, and H. Mori Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice Carcinogenesis, May 1, 2004; 25(5): 821 - 825. [Abstract] [Full Text] [PDF]

				S. Kovacic, C.-L. M. Soltys, A. J. Barr, I. Shiojima, K. Walsh, and J. R. B. Dyck Akt Activity Negatively Regulates Phosphorylation of AMP-activated Protein Kinase in the Heart J. Biol. Chem., October 10, 2003; 278(41): 39422 - 39427. [Abstract] [Full Text] [PDF]

				N. Yahagi, H. Shimano, T. Matsuzaka, Y. Najima, M. Sekiya, Y. Nakagawa, T. Ide, S. Tomita, H. Okazaki, Y. Tamura, et al. p53 Activation in Adipocytes of Obese Mice J. Biol. Chem., July 3, 2003; 278(28): 25395 - 25400. [Abstract] [Full Text] [PDF]

				L. Pirola, S. Bonnafous, A. M. Johnston, C. Chaussade, F. Portis, and E. Van Obberghen Phosphoinositide 3-Kinase-mediated Reduction of Insulin Receptor Substrate-1/2 Protein Expression via Different Mechanisms Contributes to the Insulin-induced Desensitization of Its Signaling Pathways in L6 Muscle Cells J. Biol. Chem., April 25, 2003; 278(18): 15641 - 15651. [Abstract] [Full Text] [PDF]

				H. Hori, T. Sasaoka, H. Ishihara, T. Wada, S. Murakami, M. Ishiki, and M. Kobayashi Association of SH2-Containing Inositol Phosphatase 2 With the Insulin Resistance of Diabetic db/db Mice Diabetes, August 1, 2002; 51(8): 2387 - 2394. [Abstract] [Full Text] [PDF]

				G. Jiang, Q. Dallas-Yang, Z. Li, D. Szalkowski, F. Liu, X. Shen, M. Wu, G. Zhou, T. Doebber, J. Berger, et al. Potentiation of Insulin Signaling in Tissues of Zucker Obese Rats After Acute and Long-Term Treatment With PPAR{gamma} Agonists Diabetes, August 1, 2002; 51(8): 2412 - 2419. [Abstract] [Full Text] [PDF]

				C. Taghibiglou, F. Rashid-Kolvear, S. C. Van Iderstine, H. Le-Tien, I. G. Fantus, G. F. Lewis, and K. Adeli Hepatic Very Low Density Lipoprotein-ApoB Overproduction Is Associated with Attenuated Hepatic Insulin Signaling and Overexpression of Protein-tyrosine Phosphatase 1B in a Fructose-fed Hamster Model of Insulin Resistance J. Biol. Chem., January 4, 2002; 277(1): 793 - 803. [Abstract] [Full Text]

				S. T. Nadler, J. P. Stoehr, M. E. Rabaglia, K. L. Schueler, M. J. Birnbaum, and A. D. Attie Normal Akt/PKB with reduced PI3K activation in insulin-resistant mice Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1249 - E1254. [Abstract] [Full Text] [PDF]